Pfizer says its vaccine continues to be effective against COVID-19 up to six months later.
Pfizer and its German partner, BioNTech, announced updated results Thursday from their ongoing late-stage study of more than 44,000 volunteers.
The companies said the vaccine was 91% effective against symptomatic disease and was even more protective in preventing severe disease. Of 927 confirmed COVID-19 cases detected through March 13, 77 were among people who received the vaccine and 850 were among people who got dummy shots.
There were no serious safety concerns and the vaccine also appeared to work against a variant first detected in South Africa, the companies said.
The U.K. and U.S. gave the emergency green light to roll out Pfizer’s vaccine late last year followed by many other countries. The vaccine is authorized for ages 16 and up.
This week, the companies said the vaccine is safe and strongly protective in kids as young as 12, based on a study of 2,260 U.S. volunteers.
Mortgage rates have dropped below 7% for the first time since the middle of August.
Taylor Swift grossed nearly $2 billion this year, according to Billboard.
A study from US News and World Report has found the most affordable place to retire is in Ohio.
Millions of households could see higher internet costs next year as the affordable connectivity program could end.
Viveca Chow, NYC lifestyle expert, spoke with Cheddar News to provide tips on how to have some festive fun in the city on a budget.
Apple announced that it's releasing an iPhone security update to prevent attackers from acquiring users' private passcodes.
As the new year approaches, many people are looking to find a job with a higher salary or are planning to ask their current boss for a raise. Taliya Bashani, real estate attorney and negotiation expert, joined Cheddar News to provide tips on how to properly and better negotiate better financial terms.
Meta says it will start testing a program that would allow posts from Threads to appear on other social media sites.
Several healthcare companies are reportedly joining President Biden's artificial intelligence risk management plan.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
